Declines in PDE4B activity promote myopia progression through downregulation of scleral collagen expression.
Animals
Collagen
/ metabolism
Cyclic Nucleotide Phosphodiesterases, Type 4
/ biosynthesis
Disease Models, Animal
Disease Progression
Down-Regulation
/ genetics
Female
Gene Expression Regulation
Guinea Pigs
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Microscopy, Electron
Myopia, Degenerative
/ diagnosis
RNA
/ genetics
Refraction, Ocular
/ physiology
Sclera
/ metabolism
Collagen
Form-deprivation myopia (FDM)
Myopia
Pde4b-knockout mice
Phosphodiesterase 4B (PDE4B)
Rolipram
Journal
Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
25
04
2021
revised:
19
08
2021
accepted:
02
09
2021
pubmed:
11
9
2021
medline:
16
12
2021
entrez:
10
9
2021
Statut:
ppublish
Résumé
Myopia is the most common cause of a visual refractive error worldwide. Cyclic adenosine monophosphate (cAMP)-linked signaling pathways contribute to the regulation of myopia development, and increases in cAMP accumulation promote myopia progression. To pinpoint the underlying mechanisms by which cAMP modulates myopia progression, we performed scleral transcriptome sequencing analysis in form-deprived mice, a well-established model of myopia development. Form deprivation significantly inhibited the expression levels of genes in the cAMP catabolic pathway. Quantitative real-time polymerase chain reaction analysis validated that the gene expression level of phosphodiesterase 4B (PDE4B), a cAMP hydrolase, was downregulated in form-deprived mouse eyes. Under visually unobstructed conditions, loss of PDE4B function in Pde4b-knockout mice increased the myopic shift in refraction, -3.661 ± 1.071 diopters, more than that in the Pde4b-wildtype littermates (P < 0.05). This suggests that downregulation and inhibition of PDE4B gives rise to myopia. In guinea pigs, subconjunctival injection of rolipram, a selective inhibitor of PDE4, led to myopia in normal eyes, and it also enhanced form-deprivation myopia (FDM). Subconjunctival injection of dibutyryl-cyclic adenosine monophosphate, a cAMP analog, induced only a myopic shift in the normal visually unobstructed eyes, but it did not enhance FDM. As myopia developed, axial elongation occurred during scleral remodeling that was correlated with changes in collagen fibril thickness and distribution. The median collagen fibril diameter in the FDM + rolipram group, 55.09 ± 1.83 nm, was thinner than in the FDM + vehicle group, 59.33 ± 2.06 nm (P = 0.011). Thus, inhibition of PDE4 activity with rolipram thinned the collagen fibril diameter relative to the vehicle treatment in form-deprived eyes. Rolipram also inhibited increases in collagen synthesis induced by TGF-β2 in cultured human scleral fibroblasts. The current results further support a role for PDE enzymes such as PDE4B in the regulation of normal refractive development and myopia because either loss or inhibition of PDE4B function increased myopia and FDM development through declines in the scleral collagen fibril diameter.
Identifiants
pubmed: 34506801
pii: S0014-4835(21)00324-9
doi: 10.1016/j.exer.2021.108758
pii:
doi:
Substances chimiques
RNA
63231-63-0
Collagen
9007-34-5
Cyclic Nucleotide Phosphodiesterases, Type 4
EC 3.1.4.17
PDE4B protein, mouse
EC 3.1.4.17
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108758Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.